Dalbavancin and oritavancin in long-term suppressive therapy: Use, safety, dosing regimens and the role of therapeutic drug monitoring, protocol for a systematic review. (PubMed, Farm Hosp) - Oct 8, 2026 - "The current evidence on this topic is mainly limited to small studies, which show considerable variability in treatment schedules and reported outcomes. The protocol for this systematic review is the first step to synthesise evidence on this topic to support decision-making."
Journal • Infectious Disease
|
|
Alba Martin Val; Carla Codina-Jiménez; Esteban Reynaga Sosa; Javier Díez de Los Ríos; Maite Bosch-Peligero; Marlene Álvarez Martins; Raquel Gil-Bardaji; Sergio Marín
|